Andreas Halvorsen's ARTV Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 2.6 M shares of Artiva Biotherapeutics, Inc. (ARTV) worth $25.26 M, representing 0.07% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Andreas Halvorsen has initiated a new position in ARTV, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Artiva Biotherapeutics (ARTV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Artiva Biotherapeutics (ARTV) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2.6 M | New Buy | 2.6 M | $9.70 |
Andreas Halvorsen's Artiva Biotherapeutics Investment FAQs
Andreas Halvorsen first purchased Artiva Biotherapeutics, Inc. (ARTV) in Q2 2026, acquiring 2,604,166 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Artiva Biotherapeutics, Inc. (ARTV) for 1 quarters since Q2 2026.
Andreas Halvorsen's largest addition to Artiva Biotherapeutics, Inc. (ARTV) was in Q2 2026, adding 2,604,166 shares worth $25.26 M.
According to the latest 13F filing for Q2 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 2,604,166 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $25.26 M.
As of the Q2 2026 filing, Artiva Biotherapeutics, Inc. (ARTV) represents approximately 0.07% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Artiva Biotherapeutics, Inc. (ARTV) was 2,604,166 shares, as reported at the end of Q2 2026.